Hormone replacement therapy: management of common problems
- PMID: 7630222
- DOI: 10.4065/70.8.800
Hormone replacement therapy: management of common problems
Abstract
Objective: To describe common pitfalls associated with hormone replacement therapy (HRT) and recommendations to prevent or ameliorate them.
Design: After pertinent articles and texts were reviewed, we outlined the available regimens of HRT, the commonly encountered side effects, and the management options.
Results: HRT is frequently prescribed for elderly women. Vaginal bleeding, nausea, breast tenderness, migraine headaches, mood alterations, and abdominal bloating are common occurrences with HRT. These problems often can be managed by changing the dose, using another preparation or regimen, or altering the route of administration. For example, transdermal administration of estradiol may be tolerated better than oral therapy in patients with nausea. Irregular bleeding warrants endometrial biopsy to rule out hyperplasia.
Conclusion: With simple measures, common side effects of HRT can easily be managed by primary-care physicians. Gynecologic referral is recommended when endometrial biopsy is necessary or when symptoms fail to respond to adjustments in hormone therapy.
Comment in
-
Estrogen replacement therapy.Mayo Clin Proc. 1996 Feb;71(2):212-3. doi: 10.4065/71.2.212-a. Mayo Clin Proc. 1996. PMID: 8577199 No abstract available.
-
Estrogen replacement therapy.Mayo Clin Proc. 1996 Feb;71(2):212, author reply 212-3. doi: 10.1016/S0025-6196(11)64517-5. Mayo Clin Proc. 1996. PMID: 8577200 No abstract available.
Similar articles
-
Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.Pharmacoeconomics. 1994 May;5(5):419-45. doi: 10.2165/00019053-199405050-00008. Pharmacoeconomics. 1994. PMID: 10147233 Review.
-
Hormone replacement therapy and cancer.Gynecol Endocrinol. 2001 Dec;15(6):453-65. Gynecol Endocrinol. 2001. PMID: 11826770 Review.
-
Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.Climacteric. 2001 Sep;4(3):181-93. Climacteric. 2001. PMID: 11588941 Review.
-
Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.Climacteric. 2001 Mar;4(1):42-8. Climacteric. 2001. PMID: 11379377 Clinical Trial.
-
Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.Drugs Aging. 1997 Oct;11(4):309-32. doi: 10.2165/00002512-199711040-00006. Drugs Aging. 1997. PMID: 9342560 Review.
Cited by
-
Retrospective Analysis of Effective Management Strategies for Primary Amenorrhea of Reproductive Age in Saudi Arabia.Life (Basel). 2024 Jun 17;14(6):772. doi: 10.3390/life14060772. Life (Basel). 2024. PMID: 38929754 Free PMC article.
-
Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial.BMC Womens Health. 2008 Mar 26;8:5. doi: 10.1186/1472-6874-8-5. BMC Womens Health. 2008. PMID: 18366766 Free PMC article. Clinical Trial.
-
Abnormal bleeding during menopause hormone therapy: insights for clinical management.Clin Med Insights Womens Health. 2013 Jan 23;6:13-24. doi: 10.4137/CMWH.S10483. eCollection 2013. Clin Med Insights Womens Health. 2013. PMID: 24665210 Free PMC article. Review.
-
[Migraine and hormones: what can we be certain of?].Schmerz. 2008 Feb;22 Suppl 1:31-6. doi: 10.1007/s00482-007-0613-9. Schmerz. 2008. PMID: 18256855 Review. German.
-
Use of Systemic Steroids, Hormone Replacement Therapy, or Oral Contraceptives Is Associated with Decreased Implant Survival in Women.Dent J (Basel). 2023 Jun 29;11(7):163. doi: 10.3390/dj11070163. Dent J (Basel). 2023. PMID: 37504229 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources